Artificial intelligence (AI) isn't the only industry with explosive growth potential.

They could perhaps see sustained runs beyond this year.

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued stocks in the Biotechnology industry for Tuesday, January 13, 2026. Let’s ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Shares Biotechnology ETF earns a reiterated hold rating as it consolidates near all-time highs with balanced risk/reward.

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...